DKMA Update March 2018

This newsletter features the following articles:

• Evidence on the agenda
• The SmPC for tramadol to be changed
• Inspection of the sale of over-the-counter medicines outside pharmacies
• Do not use Xofigo for treatment of prostate cancer in combination with Zytiga and the anti-inflammatory agents prednisone/prednisolone
• Rare but possible risk of liver injury in the treatment of fibroids with the medicine Esmya
• Multiple sclerosis medicine Zinbryta removed from the market

Short news:

• New status report on biological medicines and biosimilars
• Scientific advice to promote research and innovation
• Short film about the medicinal cannabis pilot programme

Link

DKMA Update March 2018 (pdf)